Serlopitant
N/A
Report date: 2025/02/14 20:00:40
NME
Base Information
Drug NameSerlopitant
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMenlo Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesStanford UniversityMenlo Therapeutics Inc
Inactive CompaniesVyne Therapeutics Inc
Active Indications
Inactive Indications +[9]